GlassScriptPhysician profile
Hector Alejandro Preti
NPI 1861484628
$11,438.80
in general payments reported to CMS, 2019-2025
66 companies · $959 in 2025
The $959 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,919 · 2020: $328 · 2022: $2,467 · 2023: $2,601 · 2024: $1,164 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,714 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,713.56 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $3,322.72 | 2019-2023 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $973.53 | 2022-2025 | |
| Pfizer INC. | $596.47 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $434.75 | 2019-2025 | Keytruda, Lynparza, Welireg |
| E.R. Squibb & Sons, L.L.C. | $393.62 | 2019-2025 | Opdivo, Eliquis |
| Astrazeneca Pharmaceuticals LP | $363.99 | 2019-2025 | Imfinzi, Calquence |
| Gilead Sciences, INC. | $305.58 | 2019-2025 | Trodelvy |
| Amgen INC. | $298.63 | 2019-2023 | Kyprolis, Blincyto, Lumakras |
| Incyte Corporation | $276.83 | 2022-2025 | Jakafi, Monjuvi |
| Janssen Biotech, INC. | $267.71 | 2019-2023 | Darzalex, Imbruvica, Erleada |
| Daiichi Sankyo INC. | $258.87 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Astellas Pharma US INC | $236.02 | 2019-2023 | Xtandi, Xospata |
| Takeda Pharmaceuticals U.S.A., INC. | $235.82 | 2022-2025 | Alunbrig, Iclusig, Fruzaqla |
| Bayer Healthcare Pharmaceuticals INC. | $225.86 | 2019-2025 | |
| Eisai INC. | $223.68 | 2019-2025 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $176.50 | 2022-2025 | Onivyde, Somatuline Depot |
| Celgene Corporation | $152.38 | 2019-2025 | Reblozyl, Pomalyst |
| Emd Serono, INC. | $147.77 | 2019-2025 | Bavencio |
| Seagen INC. | $146.95 | 2022-2023 | Tukysa, Adcetris, Padcev |
| Genentech USA, INC. | $129.42 | 2019-2023 | Alecensa, Tecentriq, Lunsumio |
| Kite Pharma, INC. | $125.39 | 2020-2023 | |
| Beigene USA, INC. | $124.66 | 2023-2024 | Brukinsa |
| Tersera Therapeutics LLC | $123.20 | 2019-2024 | Zoladex, Xermelo, Quzyttir |
| Adaptive Biotechnologies Corporation | $109.77 | 2022-2023 | Clonoseq |
| Pharmaessentia USA Corporation | $101.61 | 2022-2023 | Besremi |
| Coherus Oncology, INC. | $100.09 | 2022-2023 | |
| Genzyme Corporation | $95.31 | 2022-2023 | |
| Puma Biotechnology, INC. | $85.92 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $82.44 | 2022-2024 | Zepzelca |
| Regeneron Healthcare Solutions, INC. | $79.14 | 2022-2023 | Libtayo |
| Rigel Pharmaceuticals, INC. | $78.07 | 2019-2023 | Tavalisse, Rezlidhia |
| Morphosys, US INC. | $70.97 | 2023 | Monjuvi |
| Taiho Oncology, INC. | $69.88 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.50 | 2022-2023 | Gilotrif |
| Eusa Pharma (US) LLC | $65.42 | 2022 | |
| Octapharma USA, INC. | $59.59 | 2023 | Panzyga |
| Aveo Pharmaceuticals, INC. | $51.81 | 2022-2023 | Fotivda |
| Dendreon Pharmaceuticals LLC | $48.85 | 2022-2023 | Provenge |
| Genmab U.S., INC. | $48.49 | 2022 | |
| Epizyme, INC. | $47.15 | 2022 | |
| Verastem, INC. | $43.57 | 2019 | |
| Mirati Therapeutics, INC. | $43.21 | 2023 | Krazati |
| Array Biopharma INC | $38.67 | 2024 | Braftovi, Mektovi |
| Organon LLC | $34.98 | 2022-2023 | Ontruzant |
| Ge Healthcare | $33.99 | 2022 | |
| Deciphera Pharmaceuticals INC. | $33.37 | 2023 | Qinlock |
| Syndax Pharmaceuticals, INC. | $30.30 | 2025 | |
| Pharmacosmos Therapeutics INC. | $29.30 | 2025 | Monoferric |
| Karyopharm Therapeutics INC. | $27.31 | 2022 | |
| Spectrum Pharmaceuticals INC. | $26.84 | 2023 | Rolvedon |
| Menarini Silicon Biosystems, INC. | $26.63 | 2023 | Cellsearch |
| Beone Medicines USA, INC. | $26.61 | 2025 | Brukinsa |
| Inari Medical, INC. | $24.46 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Myriad Genetic Laboratories, INC. | $24.20 | 2022 | |
| Sirtex Medical INC | $22.02 | 2023 | Sir-Spheres Microspheres |
| Cti Biopharma Corp. | $20.77 | 2022 | |
| Tempus Ai, INC | $20.66 | 2024 | |
| Servier Pharmaceuticals LLC | $19.91 | 2024 | |
| Apellis Pharmaceuticals, INC. | $19.59 | 2022 | |
| Agios Pharmaceuticals, INC. | $17.78 | 2023 | |
| Abbvie INC. | $17.28 | 2023 | |
| Fresenius Kabi USA, LLC | $16.83 | 2025 | Stimufend |
| Lilly USA, LLC | $15.42 | 2023 | Jaypirca, Retevmo, Verzenio |
| Glaxosmithkline, LLC. | $12.60 | 2022 | |
| Stemline Therapeutics INC. | $12.14 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Preti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.